Sherkow publishes new article on new genomic technologies 

Professor Jacob Sherkow is co-author of a new article in International Review of Intellectual Property and Competition Law focused on new genomic technologies. “Intellectual Property, New Genomic Technologies and Plant Innovation: Clearing Innovation Pathways” focuses on how new genomic technologies may revolutionize agriculture, but how United States and European Union patent protections may hinder their implementation.

Sherkow provides Master Class presentation

In October, Professor Jacob Sherkow gave a Master Class presentation at the University of Copenhagen on Advanced Biotechnology and Advanced Regulation, that assessed recent biotechnological advancements with regulatory paradigms in the United States and the European Union. The class is a tuition-free, ten-session online program for legal, medical, scientific, and policy professionals working at the frontier of health & life-science innovation. Each class consists of a 3-hour session of expert teaching with case discussion and a question and answer session.

Sherkow helps correct record on peptides

Influencers have shared viewpoints widely on peptides across the internet, and recently a panel that advises the FDA voted to loosen restrictions on vetting of experimental peptides. To help consumers understand fact from fiction on peptides, USA Today highlighted the myths and red flags around these drugs. Professor Jacob Sherkow lent his expertise to the article, helping to dispel falsehoods.

Chemistry World quotes Sherkow on Merck antibiotic withdrawal

Merck & Co.’s decision to discontinue its intravenous antibiotic combination Recarbrio has led to a shortage of medicine used to treat antibiotic-resistant infections. In dissecting the issue, Chemistry World quoted Professor Jacob Sherkow, an expert in patents, about whether a generic drug could be manufactured to make up for the shortage. “These are very complicated drugs to manufacture, often needing their own manufacturing facility to avoid cross-contamination, which is an expensive endeavor for a generics company,” he said.

Lawsky invested as L.B. Lall and Sumitra Devi Lall Professor of Law

On October 13, 2026, Sarah Lawsky was invested as the L.B. Lall and Sumitra Devi Lall Professor of Law in a ceremony at the College of Law Building. At the ceremony, Dean Jamelle Sharpe hailed Professor Lawsky for the way she has endeared herself to the faculty and the University of Illinois community. He shared a quote from her peer, Professor Lesley Wexler, who said Lawsky is “deeply committed, deeply curious and willing to keep digging and tweaking until she’s satisfied she has really addressed the problem at hand…. I’m often reminded how thrilled I am Sarah joined us: thrilled as a colleague and thrilled as a friend.”

Professor Lawsky joined the University of Illinois College of Law faculty in 2025. She studies tax law, computational law, and the intersection of the two. Her recent work focuses on the formalization of tax law. Professor Lawsky’s research arguing for using a particular nonstandard logic to formalize tax law is the conceptual foundation for the domain-specific programming language Catala, which is the project of a team of computer scientists and lawyers. Before joining the University of Illinois, Professor Lawsky taught at Northwestern Pritzker School of Law, UC Irvine School of Law, and George Washington University Law School. Before entering academia, she worked as a tax lawyer for large law firms.

Sherkow quoted in Bloomberg on seed technology patent case

Corteva Inc. v. Inari Agriculture Inc. was a closely watched case in the world of biological materials patents. When it ended in a settlement, however, it was a missed opportunity for the courts to come to a ruling on patents for plant varieties. Speaking with Bloomberg, Professor Jacob Sherkow explained that Inari’s decision to settle and place biological materials it obtained into a repository might make similar deals more appealing in future cases. ““You can deposit and get your patents without worrying that everyone will just design around,” he said.

Rowell presents work at The Next Frontier: Rethinking Regulation in an Era of Rapid Innovation

On September 25, Professor Arden Rowell presented on how to regulate emerging technologies, like AI, at the Regulatory Studies Center at George Washington University. She was part of two panels, one on designing adaptive regulation and frameworks and another on regulation of emerging technology; she also submitted a working paper as part of the event.

Sherkow publishes paper on genome-edited microbes

In the search for new means of sustainability in agriculture, genome-edited microbes represent a promising tool. In a new paper, Professor Jacob Sherkow investigates the regulatory issues and differences between the US and EU approaches, including recent EU legislation. The article suggests that there are lessons to be learned on both sides and provides recommendations for future regulations.

Rowell op-ed: The End of NRC Independence and the Future of Nuclear Safety

What does the future of nuclear safety look like, and what might still be done to reduce the risk of nuclear disaster, given the demise of NRC independence following the Supreme Court decision in Trump v. Slaughter? An op-ed from Professor Arden Rowell and co-author Jud Mathews published in The Regulatory Review attempts to answer these questions.

Gerke named 2026-27 University Scholar

Sara Gerke is among five professors at the University of Illinois Urbana-Champaign that have been named 2026-2027 University Scholars in recognition of their achievements in teaching, scholarship and service. The program honors faculty excellence and provides $15,000 to each scholar for three years to enhance their academic careers. That money may be used for travel, equipment, research assistants, books or other purposes.

Gerke, the Richard W. and Marie L. Corman Scholar at the College of Law, is an expert in health law and bioethics with a particular focus on artificial intelligence and digital health. She also holds an affiliation as a professor in the European Union Center at Illinois.

Gerke’s research examines the ethical and legal challenges of AI and big data in healthcare as well as health law in the U.S. and Europe. She has led or contributed to numerous interdisciplinary projects that draw on her expertise in these fields, especially in emerging medical technologies such as artificial intelligence, robotics, bionics and stem cell research. Currently, Gerke is leading two major Illinois studies funded by the European Union through the Horizon Europe funding program: the legal and ethical implications of AI-assisted surgeries and the concerns raised by the use of AI in colonoscopies. With the explosion of interest in subject matters related to her research, Gerke’s work and perspective are in demand. She has more than 100 publications in her portfolio, is a frequent guest lecturer at institutions across the world and served as an external reviewer for the World Health Organization’s guidance on the “Ethics and Governance of Artificial Intelligence for Health.” 

Learn more about the other faculty members selected for this prestigious honor at news.illinois.edu.

College of Law
504 East Pennsylvania Avenue
Champaign, IL 61820
(217) 333-0931